GeekWire
JANUARY 13, 2021
Less than three years after it was founded and with no revenue on the books, Sana Biotechnology has f iled to go public. And like many biotechnology companies it is losing money. It had accumulated a deficit of $316 million as of last September, and its net loss for the first nine months of last year totaled $172 million.
GeekWire
DECEMBER 27, 2022
He’s now CEO of Nautilus Biotechnology, and he’s not taking any big chances in the current economic downturn. In Washington, Absci , Zymeworks , TwinStrand Biosciences , NanoString Technologies and Sana Biotechnology all shed employees in 2022. government and nonprofits, supplementing income from its commercial collaborations and $27.7
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
GeekWire
SEPTEMBER 23, 2021
It will raise more than $300 million in net proceeds as part of the IPO, one of the largest ever for a Seattle-area tech company. It was an ambitious vision, particularly given the rules and regulations governing cross-border money movement. million net loss in the first six months of this year. Remitly CEO Matt Oppenheimer.
Trends in the Living Networks
MARCH 23, 2011
Their joint work on a process for cloning genes in microorganisms resulted in three patents that formed the foundation of the nascent biotechnology industry. Today, many government organizations that issue tenders for consulting work specify that any intellectual property generated in the engagement is owned by the client.
Trends in the Living Networks
AUGUST 11, 2022
In an interview with Foresight for Development , Njonjo discusses the many benefits that foresight methodologies can bring to African governments, including “proactive policies and legislation”, “better solutions to complex problems”, “reducing the number of catastrophes”, and “better use of resources”.
Expert insights. Personalized for you.
126 
Let's personalize your content